Please login to the form below

Not currently logged in
Email:
Password:

Endocyte

This page shows the latest Endocyte news and features for those working in and with pharma, biotech and healthcare.

Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer

Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer

Novartis gained 177Lu-PSMA-617 as part of its $2.1bn acquisition of Endocyte, which had a focus on radiopharmaceutical drugs for cancer, in October 2018. ... At the time, Novartis said radiopharma was a “key growth driver” for its business and that

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Novartis. Deal Type. Deal with. Details. Value. Acquisition. Endocyte. Portfolio of products and technology for. ... Endocyte’s adaptor controlled CAR‐T technology delivers the molecule FITC to the tumour through a tumour‐targeted ligand.

  • Charting a course for expansion Charting a course for expansion

    and eastern Europe - and US biotech Endocyte.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...